Low molecular weight inhibitors of Myc-Max interaction and function

Oncogene

Volumn 22, Issue 40, 2003, Pages 6151-6159

  Yin, Xiaoying ^a   Giap, Christine ^a   Lazo, John S ^b,c   Prochownik, Edward V ^a,c,d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Department of Pharmacology ^*  (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

bHLH proteins; Leucine zipper proteins; Mad; Yeast two hybrid assay

Indexed keywords

1 (3 CHLOROPHENYL) 3 DIETHYLAMINOPYRROLIDINE 2,5 DIONE; 1 [2,5 DIOXO 1 (4 PROPOXYPHENYL)PYRROLIDIN 3 YL]PIPERIDINE 4 CARBOXYLIC ACID; 3 [3 (3,6 DICHLOROCARBAZOL 9 YL) 2 HYDROXYPROPYL]THIAZOLIDINE 2,4 DIONE; 4 METHYL 2 [N' (6 METHYL 2 PHENYLCHROMAN 4 YLIDENE)HYDRAZINO]THIAZOLE 5 CARBOXYLIC ACID (3 NITROPHENYL)AMIDE; 5 (4 ETHYLBENZYLIDENE) 2 THIOXOTHIAZOLIDIN 4 ONE; BICYCLO[2.2.1]HEPT 2 YL[2 (4 NITROPHENYL)ETHYL]AMINE; BIPHENYL 2 YL (7 NITROBENZO[1,2,5]OXADIAZOL 4 YL)AMINE; HELIX LOOP HELIX PROTEIN; LEUCINE ZIPPER PROTEIN; MAX PROTEIN; MYC PROTEIN; ONCOPROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; IC 50; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; DIMERIZATION; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, MYC; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUCINE ZIPPERS; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; MAMMALIA;

EID: 0142057146     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206641     Document Type: Article

References (47)

1. Auvinen M, Paasinen A, Anderson LC and Holtta E. (1992). Nature, 360, 355-358.
2. Bai C and Elledge SJ. (1996). Methods Enzymol., 213, 331-347.
3. Baudino TA and Cleveland JL. (2001). Mol. Cell. Biol., 21, 691-702.
4. Bello-Fernandez C, Packham G and Cleveland JL. (1993). Proc. Natl Acad. Sci. USA, 90, 7804-7809.
5. Bengal E, Flores O, Rangarajan PN, Chen A, Weintraub H and Verma IM. (1994). Proc. Natl. Acad. Sci. USA, 91, 6221-6225.
6. Berg T, Cohen SB, Desharnais J, Sonderegger C, Maslyar DJ, Goldberg J, Boger DL and Vogt PK. (2002). Proc. Natl. Acad. Sci. USA, 99, 3830-3835.
7. Bowlin TL, McKnown B and Sunkara P. (1986). Cell Immunol., 98, 341-350.
8. Brandvold KA, Neiman P and Ruddell A. (2000). Oncogene, 19, 2780-2785.
9. Chen J, Willingham T, Margraff LR, Schreiber-Agus N, DePinho RA and Nissen PD. (1995). Nat. Med., 1, 638-643.
10. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR. (2000). Proc. Natl. Acad. Sci. USA, 97, 3260-3265.
11. Dang CV. (1999). Mol. Cell. Biol., 19, 1-11.
12. deAlboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert L, Rajewsky K, DePinho RA and Alt FW. (2001). Immunity, 14, 45-55.
13. Ebinuma H, Saito H, Kosuga M, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Okuyama T and Ishii H. (2001). J. Cell. Physiol., 188, 56-66.
14. Foster BA, Coffey HA, Morin MJ and Rastinejad F. (1999). Science, 286, 2507-2510.
15. Freytag SO. (1988). Mol. Cell. Biol., 8, 1614-1624.
16. Grandori C, Cowley SM, James LP and Eisenman RN. (2000). Annu. Rev. Cell Dev. Biol., 16, 653-699.
17. Guo QM, Malek RL, Kim S, Chiao C, He M, Ruffy M, Sanka K, Lee NH, Dang CV and Liu ET. 2000. Cancer Res., 60, 5922-5928.
18. Hasskarl J and Munger K. (2002). Cancer Biol. Ther., 1, 91-96.
19. Holt JT, Redner RL and Nienhuis AW. (1988). Mol. Cell. Biol., 8, 963-973.
20. Jain M, Arvantis, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM and Felsher DW. (2002). Science, 297, 102-104.
21. Kimura S, Maekawa T, Hirakawa K, Murakami A and Abe T. (1995). Cancer Res., 55, 1379-1384.
22. Komarov PG, Komarova EA. Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV. (1999). Science, 285, 1733-1737.
23. Langlands K, Anand G, Yin X and Prochownik EV. (1997). J. Biol. Chem., 272, 19785-19793.
24. Littlewood TD, Hancock DC, Danielson PS, Parker MG and Evan I. (1995). Nucleic Acids Res., 25, 1686-1690.
25. Lüscher B and Larsson L-G. (1999). Oncogene, 18, 2995-2966.
26. Matayek MK, Obaya AJ, Adachi S and Sedivy JM. (1997). Cell Growth Differ., 8, 1039-1048.
27. Nesbit CE, Grove LE, Yin XY and Prochownik EV. (1998). Cell Growth Differ., 9, 731-741.
28. Nesbit CE, Tersak JM and Prochownik EV. (1999). Oncogene, 18, 3004-3016.
29. Nesbit CE, Tersak JM, Grove LE, Drzal A, Choi H and Prochownik EV. (2000). Oncogene, 19, 3200-3212.
30. O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P and DePinho RA. (2000). Nat. Genet., 24, 113-119.
31. Oster SK, Ho CS, Soucie EL and Penn LZ. (2002). Adv. Cancer Res., 84, 81-154.
32. Packham G and Cleveland JL. (1994). Mol. Cell. Biol., 14, 5741-5747.
33. Prochownik EV and Kukowska JF. (1986). Nature, 322, 848-850.
34. Prochownik EV, Kukowska-Latallo JF and Rodgers C. (1988). Mol. Cell. Biol., 8, 3683-3695.
35. Prochownik EV and Van Antwerp ME. (1993). Proc. Natl. Acad. Sci. USA, 90, 960-964.
36. Smith MJ, Charron-Prochownik DC and Prochownik EV. (1990). Mol. Cell. Biol., 10, 5333-5339.
37. Stern DF, Roberts AB, Roche NS, Sporn MB and Weinberg RA. (1986). Mol. Cell. Biol., 6, 870-877.
38. Turner R and Tjian R. (1989). Science, 243, 1689-1694.
39. Van Antwerp ME, Chen DG, Chang C and Prochownik EV. (1992). Proc. Natl. Acad. Sci. USA, 89, 9010-9014.
40. Van Waardenburg RC, Meijer C, Burger H, Nooter K, De Vries EG, Mulder NH and De Jong S. (1997). Int. J. Cancer, 73, 544-550.
41. Wang JL, Liu D, Zhang Z-J, Shan S, Han X, Srinivasula SM, Croce CM, Alnemri ES and Huang Z. (2000). Proc. Natl. Acad. Sci. USA, 97, 7124-7129.
42. Wechsler DS, Shelly CC, Petroff CA and Dang CV. (1997). Cancer Res., 57, 4905-4912.
43. Yin XY, Grove L, Datta N, Katula K, Long MW and Prochownik EV. (2001). Cancer Res., 61, 6487-6493.
44. Yin XY, Grove L, Datta N, Long MW and Prochownik EV. (1999a). Oncogene, 17, 1177-1184.
45. Yin XY, Grove L, Rogulski K and Prochownik EV. (2002). J. Biol. Chem., 277, 19998-20010.
46. Yin XY, Gupta K, Man WP, Levitan ES and Prochownik EV. (1999b). Oncogene, 18, 6621-6634.
47. Zhang H. Fan S and Prochownik EV. (1997). J. Biol. Chem., 272, 17416-17424.